Morton RA - Search Results

1

Expression of bone morphogenetic protein receptors type-IA, -IB and -II correlates with tumor grade in human prostate cancer tissues.

Kim IY, Lee DH, Ahn HJ, Tokunaga H, Song W, Devereaux LM, Jin D, Sampath TK, Morton RA. Kim IY, et al. Among authors: morton ra. Cancer Res. 2000 Jun 1;60(11):2840-4. Cancer Res. 2000. PMID: 10850425

2

Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.

Kim IY, Lee DH, Lee DK, Kim BC, Kim HT, Leach FS, Linehan WM, Morton RA, Kim SJ. Kim IY, et al. Among authors: morton ra. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):6046-51. Clin Cancer Res. 2003. PMID: 14676131

3

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells.

Kim IY, Lee DH, Lee DK, Ahn HJ, Kim MM, Kim SJ, Morton RA. Kim IY, et al. Among authors: morton ra. Oncogene. 2004 Oct 7;23(46):7651-9. doi: 10.1038/sj.onc.1207924. Oncogene. 2004. PMID: 15354178

4

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.

Kim IY, Lee DH, Lee DK, Kim WJ, Kim MM, Morton RA, Lerner SP, Kim SJ. Kim IY, et al. Among authors: morton ra. Cancer Res. 2004 Oct 15;64(20):7355-60. doi: 10.1158/0008-5472.CAN-04-0154. Cancer Res. 2004. PMID: 15492256

5

The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients.

Lee DH, Yang SC, Hong SJ, Chung BH, Chung HJ, Tokunaga H, Kim IY, Song YS, Lerner SP, Morton RA Jr. Lee DH, et al. Among authors: morton ra jr. Yonsei Med J. 1999 Apr;40(2):118-23. doi: 10.3349/ymj.1999.40.2.118. Yonsei Med J. 1999. PMID: 10333714 Free article.

6

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines.

Kim IY, Kim BC, Seong DH, Lee DK, Seo JM, Hong YJ, Kim HT, Morton RA, Kim SJ. Kim IY, et al. Among authors: morton ra. Cancer Res. 2002 Sep 15;62(18):5365-9. Cancer Res. 2002. PMID: 12235008

7

Metastatic prostate cancer in a transgenic mouse.

Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM. Gingrich JR, et al. Among authors: morton ra. Cancer Res. 1996 Sep 15;56(18):4096-102. Cancer Res. 1996. PMID: 8797572

8

Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway.

Kim IY, Seong DH, Kim BC, Lee DK, Remaley AT, Leach F, Morton RA, Kim SJ. Kim IY, et al. Among authors: morton ra. Cancer Res. 2002 Jul 1;62(13):3649-53. Cancer Res. 2002. PMID: 12097269

9

Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.

Ewing CM, Ru N, Morton RA, Robinson JC, Wheelock MJ, Johnson KR, Barrett JC, Isaacs WB. Ewing CM, et al. Among authors: morton ra. Cancer Res. 1995 Nov 1;55(21):4813-7. Cancer Res. 1995. PMID: 7585512

10

Prostate specific antigen as a clinical biomarker for prostate cancer: what's the take home message?

Leach FS, Koh MS, Chan YW, Bark S, Ray R, Morton RA, Remaley AT. Leach FS, et al. Among authors: morton ra. Cancer Biol Ther. 2005 Apr;4(4):371-5. doi: 10.4161/cbt.4.4.1648. Epub 2005 Apr 28. Cancer Biol Ther. 2005. PMID: 15846084 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters